July 13, 2021 Comments Off on New patent for Boehringer Ingelheim drug GLYXAMBI Posted in: Patent Added Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Boehringer Ingelheim drug GLYXAMBI appeared…
July 13, 2021 Comments Off on Which pharmaceutical companies have the most drug patents in Taiwan? Posted in: Infographic This chart shows the pharmaceutical companies with the most patents in Taiwan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
